Epsilon Historical Income Statement

EPN Stock

0.02 0.00 0.00%

Historical analysis of Epsilon Healthcare income statement accounts such as Interest Expense of 347.9 K or Selling General Administrative of 4.7 M can show how well Epsilon Healthcare performed in making a profits. Evaluating Epsilon Healthcare income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Epsilon Healthcare's future profits or losses.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Epsilon Healthcare latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Epsilon Healthcare is a good buy for the upcoming year.

Net Income Gross Profit

Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

About Epsilon Income Statement Analysis

Epsilon Healthcare Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Epsilon Healthcare shareholders. The income statement also shows Epsilon investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Epsilon Healthcare Income Statement Chart

At this time, Epsilon Healthcare's Depreciation And Amortization is comparatively stable compared to the past year. Selling General Administrative is likely to gain to about 4.7 M in 2024, despite the fact that Gross Profit is likely to grow to (2.6 M).

Selling General Administrative Ebitda Net Interest Income Selling And Marketing Expenses Other Operating Expenses

Net Interest Income

The difference between the revenue generated from a bank's interest-bearing assets and the expenses associated with paying its interest-bearing liabilities.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Epsilon Healthcare. It is also known as Epsilon Healthcare overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Epsilon Healthcare's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Epsilon Healthcare current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Epsilon Healthcare. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

	2021	2022	2023	2024 (projected)
Interest Expense	799.4K	577.5K	664.2K	347.9K
Depreciation And Amortization	1.6M	1.9M	2.1M	2.2M

Interest Expense Depreciation And Amortization

Epsilon Healthcare income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Operating Income	Ebit	Ebitda	Income Before Tax	Net Income	Net Interest Income	Interest Income	Selling And Marketing Expenses	Other Operating Expenses	Net Income From Continuing Ops	Total Operating Expenses	Reconciled Depreciation	Total Other Income Expense Net	Income Tax Expense	Research Development
Depreciation And Amortization		0.9	0.72	-0.73	-0.81	-0.76	-0.83	-0.83	-0.96	0.91	0.61	0.86	-0.82	-0.01	1.0	-0.78	0.34	0.89
Interest Expense	0.9		0.82	-0.77	-0.8	-0.75	-0.81	-0.79	-0.97	1.0	0.65	0.9	-0.78	0.3	0.9	-0.58	0.08	0.85
Selling General Administrative	0.72	0.82		-0.96	-0.92	-0.92	-0.92	-0.9	-0.81	0.83	0.9	0.93	-0.89	0.61	0.72	-0.47	0.17	0.71
Operating Income	-0.73	-0.77	-0.96		0.97	0.98	0.97	0.97	0.78	-0.77	-0.93	-0.95	0.96	-0.49	-0.73	0.6	-0.4	-0.77
Ebit	-0.81	-0.8	-0.92	0.97		1.0	1.0	1.0	0.83	-0.81	-0.85	-0.96	0.99	-0.31	-0.81	0.76	-0.4	-0.79
Ebitda	-0.76	-0.75	-0.92	0.98	1.0		0.99	0.99	0.78	-0.76	-0.86	-0.94	0.99	-0.34	-0.76	0.74	-0.4	-0.75
Income Before Tax	-0.83	-0.81	-0.92	0.97	1.0	0.99		1.0	0.85	-0.83	-0.84	-0.96	0.99	-0.29	-0.83	0.77	-0.39	-0.8
Net Income	-0.83	-0.79	-0.9	0.97	1.0	0.99	1.0		0.83	-0.8	-0.84	-0.96	0.99	-0.27	-0.83	0.79	-0.44	-0.81
Net Interest Income	-0.96	-0.97	-0.81	0.78	0.83	0.78	0.85	0.83		-0.98	-0.66	-0.89	0.82	-0.19	-0.96	0.67	-0.15	-0.85
Interest Income	0.91	1.0	0.83	-0.77	-0.81	-0.76	-0.83	-0.8	-0.98		0.66	0.9	-0.8	0.28	0.91	-0.61	0.08	0.85
Selling And Marketing Expenses	0.61	0.65	0.9	-0.93	-0.85	-0.86	-0.84	-0.84	-0.66	0.66		0.88	-0.85	0.64	0.61	-0.38	0.42	0.73
Other Operating Expenses	0.86	0.9	0.93	-0.95	-0.96	-0.94	-0.96	-0.96	-0.89	0.9	0.88		-0.96	0.39	0.86	-0.67	0.37	0.89
Net Income From Continuing Ops	-0.82	-0.78	-0.89	0.96	0.99	0.99	0.99	0.99	0.82	-0.8	-0.85	-0.96		-0.27	-0.82	0.79	-0.46	-0.82
Total Operating Expenses	-0.01	0.3	0.61	-0.49	-0.31	-0.34	-0.29	-0.27	-0.19	0.28	0.64	0.39	-0.27		-0.01	0.35	-0.22	0.13
Reconciled Depreciation	1.0	0.9	0.72	-0.73	-0.81	-0.76	-0.83	-0.83	-0.96	0.91	0.61	0.86	-0.82	-0.01		-0.78	0.34	0.89
Total Other Income Expense Net	-0.78	-0.58	-0.47	0.6	0.76	0.74	0.77	0.79	0.67	-0.61	-0.38	-0.67	0.79	0.35	-0.78		-0.47	-0.65
Income Tax Expense	0.34	0.08	0.17	-0.4	-0.4	-0.4	-0.39	-0.44	-0.15	0.08	0.42	0.37	-0.46	-0.22	0.34	-0.47		0.57
Research Development	0.89	0.85	0.71	-0.77	-0.79	-0.75	-0.8	-0.81	-0.85	0.85	0.73	0.89	-0.82	0.13	0.89	-0.65	0.57

Click cells to compare fundamentals

Epsilon Healthcare Account Relationship Matchups

Epsilon Healthcare income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	222.1K	1.6M	1.6M	1.9M	2.1M	2.2M
Interest Expense	143.7K	597.7K	799.4K	577.5K	664.2K	347.9K
Selling General Administrative	5.1M	7.0M	6.9M	3.9M	4.5M	4.7M
Total Revenue	4.8M	7.4M	5.5M	7.1M	8.2M	4.6M
Gross Profit	1.1M	2.7M	2.1M	(3.1M)	(2.8M)	(2.6M)
Operating Income	(9.0M)	(10.3M)	(7.1M)	(8.0M)	(7.2M)	(7.5M)
Ebit	(11.8M)	(10.8M)	(9.7M)	(12.6M)	(11.3M)	(11.9M)
Ebitda	(11.6M)	(9.2M)	(8.1M)	(10.8M)	(9.7M)	(10.2M)
Cost Of Revenue	3.7M	4.7M	3.4M	10.2M	11.7M	12.3M
Income Before Tax	(11.7M)	(10.9M)	(10.4M)	(13.3M)	(12.0M)	(12.6M)
Net Income Applicable To Common Shares	(11.7M)	(10.5M)	(9.2M)	(13.3M)	(12.0M)	(12.6M)
Net Income	(11.7M)	(10.9M)	(8.9M)	(13.3M)	(12.0M)	(12.6M)
Net Interest Income	(143.7K)	(597.7K)	(799.4K)	(677.6K)	(609.9K)	(640.4K)
Interest Income	183.8K	595.3K	830.6K	597.3K	686.9K	422.0K
Selling And Marketing Expenses	671.5K	841.5K	417.7K	341.4K	392.7K	511.2K
Other Operating Expenses	14.0M	18.1M	15.0M	15.1M	17.4M	14.1M
Net Income From Continuing Ops	(11.7M)	(10.9M)	(8.9M)	(12.7M)	(11.4M)	(12.0M)
Total Operating Expenses	10.4M	13.4M	11.6M	725.8K	653.3K	620.6K
Reconciled Depreciation	222.1K	1.6M	1.6M	1.9M	2.1M	2.2M
Total Other Income Expense Net	(2.3M)	260.3K	(939.1K)	(5.3M)	(4.8M)	(4.5M)
Income Tax Expense	395.6K	1.0M	(1.5M)	821.7K	739.5K	776.5K
Research Development	140.3K	472.3K	171.1K	375.6K	431.9K	264.2K

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.

Explore Investing Ideas

Additional Tools for Epsilon Stock Analysis

When running Epsilon Healthcare's price analysis, check to measure Epsilon Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Epsilon Healthcare is operating at the current time. Most of Epsilon Healthcare's value examination focuses on studying past and present price action to predict the probability of Epsilon Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Epsilon Healthcare's price. Additionally, you may evaluate how the addition of Epsilon Healthcare to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Epsilon Historical Income Statement

About Epsilon Income Statement Analysis

Epsilon Healthcare Income Statement Chart

Net Interest Income

Other Operating Expenses

Epsilon Healthcare income statement Correlations

Epsilon Healthcare Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Epsilon Healthcare income statement Accounts

Thematic Opportunities

Explore Investment Opportunities

Additional Tools for Epsilon Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Tax Provision	Depreciation And Amortization
Interest Expense	Selling General Administrative
Total Revenue	Gross Profit
Operating Income	Ebit
Ebitda	Cost Of Revenue
Income Before Tax	Net Income Applicable To Common Shares
Net Income	Net Interest Income
Interest Income	Selling And Marketing Expenses
Other Operating Expenses	Net Income From Continuing Ops
Total Operating Expenses	Reconciled Depreciation
Total Other Income Expense Net	Income Tax Expense
Research Development

Reconciled Depreciation	+ 1.0	Depreciation And Amortization
Interest Income	+ 1.0	Interest Expense
Ebitda	+ 1.0	Ebit
Income Before Tax	+ 1.0	Ebit
Net Income	+ 1.0	Ebit
Net Income	+ 1.0	Income Before Tax

Interest Income	- 0.98	Net Interest Income
Net Interest Income	- 0.97	Interest Expense
Net Income From Continuing Ops	- 0.96	Other Operating Expenses
Reconciled Depreciation	- 0.96	Net Interest Income
Other Operating Expenses	- 0.96	Net Income
Other Operating Expenses	- 0.96	Income Before Tax